دورية أكاديمية

Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study.

التفاصيل البيبلوغرافية
العنوان: Maternal serum ischemia modified albumin as a marker for hypertensive disorders of pregnancy: a pilot study.
المؤلفون: Vyakaranam S; Department of Biochemistry, Mediciti Institute of Medical Sciences, Ghanpur-501401, Medchal Mandal Ranga Reddy, Telangana, India., Bhongir AV; Department of Biochemistry, Mediciti Institute of Medical Sciences, Ghanpur-501401, Medchal Mandal Ranga Reddy, Telangana, India., Patlolla D; Department of Biochemistry, Mediciti Institute of Medical Sciences, Ghanpur-501401, Medchal Mandal Ranga Reddy, Telangana, India., Chintapally R; Department of Gynaecology & Obstetrics, Mediciti Institute of Medical Sciences, Ghanpur-501401, Medchal Mandal Ranga Reddy, Telangana, India.
المصدر: International journal of reproduction, contraception, obstetrics and gynecology [Int J Reprod Contracept Obstet Gynecol] 2015 Jun; Vol. 4 (3), pp. 611-616.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: International Journal of Reproduction, Contraception, Obstetrics and Gynecology] Country of Publication: India NLM ID: 101629365 Publication Model: Print Cited Medium: Print ISSN: 2320-1770 (Print) Linking ISSN: 23201770 NLM ISO Abbreviation: Int J Reprod Contracept Obstet Gynecol Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Ahmedabad : International Journal of Reproduction, Contraception, Obstetrics and Gynecology]
مستخلص: Background: Hypoxia driven oxidative stress of the placenta contributes to the pathogenesis of preeclampsia. Serum Ischemia Modified Albumin (IMA) has recently emerged as an oxidative stress marker, used in diagnosis of cardiac ischemia. Aim: To determine the efficiency of serum IMA in differentiating hypertensive disorders of pregnancy (pregnancy induced hypertension, preeclampsia) from normal pregnancy.
Methods: It was a case control study. Pregnant women ≥32 weeks of gestation. Study population were included 3 groups, 19 Normotensive Pregnant (NP) women as controls, 18 pregnant women with Pregnancy Induced Hypertension (PIH) and 19 with preeclampsia (PE). Serum IMA was estimated by Enzyme Linked Immune Sorbent Assay (ELISA). Results were analyzed by student 't'test. Critical values for serum IMA were obtained by Receiver Operation Characteristics (ROC) curves.
Results: Serum IMA levels were significantly elevated in PE (56.84 ± 21.57 ng/ml) when compared with PIH (36.24 ± 14.51 ng/ml) and NP (35.47 ± 11.58 ng/ml) (P value <0.001). With a cutoff of 38.33 ng/ml, sensitivity and specificity for preeclampsia was 88.9% and 73.7% respectively.
Conclusions: Our study demonstrated that serum IMA, an oxidative stress marker is elevated in PE & PIH. Hence serum IMA can undergo further evaluation as a marker of PE.
References: J Soc Gynecol Investig. 2004 Sep;11(6):342-52. (PMID: 15350246)
Am J Clin Pathol. 2005 Jan;123(1):140-5. (PMID: 15762290)
J Emerg Med. 2000 Nov;19(4):311-5. (PMID: 11074321)
Am J Kidney Dis. 2006 Mar;47(3):493-502. (PMID: 16490629)
Clin Chem. 2004 Nov;50(11):2190-3. (PMID: 15502098)
Clin Chem. 2002 Jul;48(7):1097-100. (PMID: 12089181)
Br J Obstet Gynaecol. 1998 Oct;105(10):1113-7. (PMID: 9800936)
Clin Chim Acta. 2008 Jan;387(1-2):120-7. (PMID: 17964561)
Hypertens Pregnancy. 2010 Jan;29(1):101-11. (PMID: 20132025)
Semin Perinatol. 2000 Feb;24(1):24-8. (PMID: 10709854)
Clin Biochem. 2006 Feb;39(2):143-51. (PMID: 16325791)
Br J Obstet Gynaecol. 1986 Oct;93(10):1049-59. (PMID: 3790464)
Hypertens Pregnancy. 2001;20(1):IX-XIV. (PMID: 12044323)
Am J Obstet Gynecol. 2000 Jul;183(1):S1-S22. (PMID: 10920346)
Am J Obstet Gynecol. 1998 Nov;179(5):1359-75. (PMID: 9822529)
Hypertens Pregnancy. 2014 Nov;33(4):440-8. (PMID: 25019475)
Am J Pathol. 2003 Jan;162(1):115-25. (PMID: 12507895)
Placenta. 2006 Sep-Oct;27(9-10):939-58. (PMID: 16490251)
Eur J Biochem. 2001 Jan;268(1):42-7. (PMID: 11121100)
Hypertens Pregnancy. 2008;27(2):159-67. (PMID: 18484421)
J Matern Fetal Neonatal Med. 2011 Mar;24(3):418-21. (PMID: 20617896)
Hum Reprod. 2008 Apr;23 (4):803-6. (PMID: 18281685)
معلومات مُعتمدة: D43 TW009078 United States TW FIC NIH HHS
فهرسة مساهمة: Keywords: Early marker; Ischemia modified albumin; Preeclampsia; Pregnancy induced hypertension
تواريخ الأحداث: Date Created: 20151205 Latest Revision: 20200929
رمز التحديث: 20221213
مُعرف محوري في PubMed: PMC4666021
DOI: 10.18203/2320-1770.ijrcog20150061
PMID: 26636109
قاعدة البيانات: MEDLINE
الوصف
تدمد:2320-1770
DOI:10.18203/2320-1770.ijrcog20150061